<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Johnson & Johnson on the CHF 30 million capital increase for the acquisition of an equity stake in Biocartis SA | Pestalozzi Attorneys at Law

Pestalozzi advised Johnson & Johnson on the CHF 30 million capital increase for the acquisition of an equity stake in Biocartis SA

03.2010

Johnson & Johnson took an equity stake in Biocartis, a commercial stage molecular diagnostics (MDx) company. For this purpose it increased its capital by CHF 30 million. Pestalozzi advised Johnson & Johnson on its role as co-investor.

To the top

Cookies

Okay
We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.